Sodium channel blockers for the treatment of neuropathic pain.
about
Structure of a Prokaryotic Sodium Channel Pore Reveals Essential Gating Elements and an Outer Ion Binding Site Common to Eukaryotic ChannelsAn integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US.Evaluation of the effects of novel nafimidone derivatives on thermal hypoalgesia in mice with diabetic neuropathy.Tetrodotoxin (TTX) as a therapeutic agent for pain.Voltage-gated sodium channel (NaV) protein dissection creates a set of functional pore-only proteins.Novel sodium channel antagonists in the treatment of neuropathic pain.New developments in the pharmacotherapy of neuropathic chronic pelvic pain.Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis.Sodium channel blockers for neuropathic pain.The discovery and development of analgesics: new mechanisms, new modalities.Ion channel blockers for the treatment of neuropathic pain.New investigational drugs for the treatment of neuropathic pain.Voltage gated sodium channels as drug discovery targetsPharmacological Management of Chronic Pelvic Pain in Women.Targeting voltage-gated sodium channels for treatment for chronic visceral pain.µ-Conotoxins Modulating Sodium Currents in Pain Perception and Transmission: A Therapeutic Potential.Molecular determinants of prokaryotic voltage-gated sodium channels for recognition of local anesthetics.Voltage-gated sodium channel function and expression in injured and uninjured rat dorsal root ganglia neurons.Aconitum and delphinium diterpenoid alkaloids of local anesthetic activity: comparative QSAR analysis based on GA-MLRA/PLS and optimal descriptors approach.Endothelin-1 Decreases Excitability of the Dorsal Root Ganglion Neurons via ETB Receptor.
P2860
Q27680241-2CEE97D6-76F0-425E-8BCE-B2537E546E11Q30236003-55236836-5B0D-4E8A-A4B1-6AC36FF19B52Q33974393-5D7B6708-7CD9-4E8C-9528-40D79BBB5DE9Q34260913-C483AABB-7F7C-42B7-8B18-546BB3CBE854Q35134111-81DDDDB1-141A-4D50-B33C-E920AC157C22Q35843983-49299211-E2BF-4886-8227-734B4E855CF9Q37591842-8D32202C-63DB-4C0C-B8DE-B840AB45191EQ37635600-B150844C-A5C1-445A-BADF-17FA1E5DFB6AQ37729164-367E81B2-9483-49E3-8116-E054A0780583Q37805995-781CD01D-FA6F-4F4D-AA26-3ED3C48A7F31Q37855929-A5BE37DF-B01E-4924-AC10-D172F193CED5Q38217614-436CBBAB-DCA3-46C6-A7A5-B9DE6042D1FAQ38662546-5EE17D63-60D3-4EDC-B516-4D55A108DD3AQ39078993-C36D08C8-BD50-4F0E-8EF6-316B67B9C050Q42740849-E660B4A2-624D-4AE4-9BCC-4BFB1F191DD9Q45384168-8D3FED56-8D88-42DD-8D5C-C2FC84AC2F60Q47422850-3AED28D1-3511-48DA-982A-4CBA0201785DQ47766649-DAC22B69-BEB4-4AB3-8F5F-141E6E52D6C2Q47813418-304F289F-C224-4D5A-A0F0-DAEAD0841BB0Q54088777-95CD2153-5A40-4463-B8D1-F18B93A0B529
P2860
Sodium channel blockers for the treatment of neuropathic pain.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sodium channel blockers for the treatment of neuropathic pain.
@en
Sodium channel blockers for the treatment of neuropathic pain.
@nl
type
label
Sodium channel blockers for the treatment of neuropathic pain.
@en
Sodium channel blockers for the treatment of neuropathic pain.
@nl
prefLabel
Sodium channel blockers for the treatment of neuropathic pain.
@en
Sodium channel blockers for the treatment of neuropathic pain.
@nl
P2093
P2860
P1433
P1476
Sodium channel blockers for the treatment of neuropathic pain.
@en
P2093
Alan D Wickenden
Anindya Bhattacharya
Sandra R Chaplan
P2860
P2888
P304
P356
10.1016/J.NURT.2009.08.001
P577
2009-10-01T00:00:00Z
P5875
P6179
1012991380